Skip to main content

Find Clinical Trials

Home
Conditions
Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer

Clinical trial condition

Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer

Explore clinical trials studying Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer trial results

Not Yet Recruiting

A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)

NCT07054242

Conditions: Neoadjuvant Therapy, Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer
Locations: Department of Breast Surgery, Yantai Yuhuangding Hospital Yantai, Shandong, China

View Trial Details

Neoadjuvant Therapy (1)